Report overview
Marijuana (medical cannabis) is used to treat nausea, pain, anxiety, MS, insomnia, epilepsy, and other conditions. Tetrahydrocannabinol (THC) and cannabidiol (CBD) are the main chemicals used in medicine. In the medicines market, Epidiolex, the first cannabis-based medication approved by the US Food and Drug Administration.
This report aims to provide a comprehensive presentation of the global market for Cannabis-based Medicines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cannabis-based Medicines. This report contains market size and forecasts of Cannabis-based Medicines in global, including the following market information:
Global Cannabis-based Medicines Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Cannabis-based Medicines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
CBD (Cannabidiol) Based Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cannabis-based Medicines include GW Pharmaceuticals plc, INSYS Therapeutics, Aequus Pharmaceuticals, Axim Biotechnologies, Revive Therapeutics, MGC Pharmaceuticals and ECHO Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cannabis-based Medicines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cannabis-based Medicines Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Cannabis-based Medicines Market Segment Percentages, by Type, 2022 (%)
CBD (Cannabidiol) Based
THC (Tetrahydrocannabinol) Based
Others
Global Cannabis-based Medicines Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Cannabis-based Medicines Market Segment Percentages, by Application, 2022 (%)
Oral Solution
Tablets
Patches
Others
Global Cannabis-based Medicines Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Cannabis-based Medicines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cannabis-based Medicines revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cannabis-based Medicines revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GW Pharmaceuticals plc
INSYS Therapeutics
Aequus Pharmaceuticals
Axim Biotechnologies
Revive Therapeutics
MGC Pharmaceuticals
ECHO Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cannabis-based Medicines, market overview.
Chapter 2: Global Cannabis-based Medicines market size in revenue.
Chapter 3: Detailed analysis of Cannabis-based Medicines company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cannabis-based Medicines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
